Avotaciclib (BEY1107) trihydrochloride 是一种有效和具有口服活性的cyclin dependent kinase 1 (CDK1)抑制剂。Avotaciclib trihydrochloride 可用于局部晚期或转移性胰腺癌的研究。
| 生物活性 | Avotaciclib (BEY1107) trihydrochloride is a potent and orally active inhibitor ofcyclin dependent kinase 1 (CDK1). Avotaciclib trihydrochloride can be used for the research of locally advanced or metastatic pancreaticcancer[1]. |
| IC50& Target[1] | |
| Clinical Trial | |
| 分子量 | |
| 性状 | |
| Formula | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | 4°C, stored under nitrogen, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture) |
